Chemed ROE 2010-2023 | CHE

Current and historical return on equity (ROE) values for Chemed (CHE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Chemed ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $0.27B $1.11B 27.48%
2023-09-30 $0.24B $1.02B 26.74%
2023-06-30 $0.23B $0.95B 26.97%
2023-03-31 $0.24B $0.88B 30.99%
2022-12-31 $0.25B $0.80B 34.68%
2022-09-30 $0.26B $0.72B 38.87%
2022-06-30 $0.28B $0.69B 40.22%
2022-03-31 $0.27B $0.67B 36.45%
2021-12-31 $0.27B $0.62B 33.59%
2021-09-30 $0.31B $0.78B 35.39%
2021-06-30 $0.30B $0.87B 34.72%
2021-03-31 $0.33B $0.93B 38.91%
2020-12-31 $0.32B $0.90B 40.80%
2020-09-30 $0.27B $0.80B 36.72%
2020-06-30 $0.26B $0.75B 37.12%
2020-03-31 $0.23B $0.68B 34.34%
2019-12-31 $0.22B $0.73B 33.92%
2019-09-30 $0.21B $0.67B 33.85%
2019-06-30 $0.20B $0.62B 33.98%
2019-03-31 $0.21B $0.59B 35.61%
2018-12-31 $0.21B $0.59B 36.90%
2018-09-30 $0.21B $0.57B 37.95%
2018-06-30 $0.19B $0.56B 36.52%
2018-03-31 $0.11B $0.51B 22.85%
2017-12-31 $0.10B $0.54B 19.88%
2017-09-30 $0.08B $0.48B 15.34%
2017-06-30 $0.07B $0.45B 13.64%
2017-03-31 $0.11B $0.50B 23.10%
2016-12-31 $0.11B $0.52B 22.27%
2016-09-30 $0.11B $0.49B 21.98%
2016-06-30 $0.11B $0.46B 22.37%
2016-03-31 $0.11B $0.49B 22.60%
2015-12-31 $0.11B $0.51B 22.69%
2015-09-30 $0.11B $0.49B 23.43%
2015-06-30 $0.11B $0.48B 23.29%
2015-03-31 $0.10B $0.48B 23.06%
2014-12-31 $0.10B $0.45B 22.56%
2014-09-30 $0.09B $0.43B 21.01%
2014-06-30 $0.09B $0.44B 19.25%
2014-03-31 $0.08B $0.45B 16.86%
2013-12-31 $0.08B $0.45B 16.74%
2013-09-30 $0.08B $0.43B 17.57%
2013-06-30 $0.09B $0.48B 17.97%
2013-03-31 $0.09B $0.48B 19.59%
2012-12-31 $0.09B $0.45B 19.68%
2012-09-30 $0.09B $0.48B 19.89%
2012-06-30 $0.09B $0.45B 20.69%
2012-03-31 $0.09B $0.43B 19.97%
2011-12-31 $0.09B $0.41B 19.19%
2011-09-30 $0.08B $0.43B 18.03%
2011-06-30 $0.08B $0.49B 16.83%
2011-03-31 $0.08B $0.46B 16.42%
2010-12-31 $0.08B $0.46B 16.34%
2010-09-30 $0.08B $0.53B 15.23%
2010-06-30 $0.08B $0.51B 15.42%
2010-03-31 $0.07B $0.50B 15.62%
2009-12-31 $0.07B $0.48B 16.33%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $9.320B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
Quest Diagnostics (DGX) United States $15.181B 15.69
DaVita (DVA) United States $11.744B 15.98
Encompass Health (EHC) United States $8.258B 22.65
Elanco Animal Health (ELAN) United States $6.651B 15.12
Option Care Health (OPCH) United States $5.317B 20.12
RadNet (RDNT) United States $3.344B 97.66
Amedisys (AMED) United States $2.978B 21.25
LifeStance Health (LFST) United States $2.326B 0.00
Astrana Health (ASTH) United States $2.077B 26.21
U.S Physical Therapy (USPH) United States $1.558B 40.39
Addus HomeCare (ADUS) United States $1.538B 23.57
Pennant (PNTG) United States $0.643B 37.58
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Atai Life Sciences (ATAI) Germany $0.330B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00